$TKCM
TOKEN COMMUNITIES LTD.

2023 Q4 Form 10-K Financial Statement

#000147793223007616 Filed on October 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q2 2023
Revenue -$276.00 $31.94K
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin 0.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $56.06K $285.9K
YoY Change 51.75% -10.24%
Operating Profit -$56.34K -$254.0K
YoY Change 52.5% -20.27%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0%
Pretax Income -$254.0K
YoY Change -5.42%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$56.34K -$61.33K $254.0K
YoY Change 52.5% -5.42%
Net Earnings / Revenue 795.34%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 2.096B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.396K $1.430K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $58.33K $46.48K
Prepaid Expenses
Receivables $50.00K $50.00K
Other Receivables
Total Short-Term Assets $113.1K $97.91K
YoY Change 124.83% 94.61%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $817.00 $815.00
YoY Change -2.27% -2.51%
Total Long-Term Assets $817.00 $815.00
YoY Change -2.27% -2.51%
TOTAL ASSETS
Total Short-Term Assets $113.1K $97.91K
Total Long-Term Assets $817.00 $815.00
Total Assets $113.9K $98.73K
YoY Change 122.75% 93.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $39.52K $62.48K
YoY Change -88.85% -82.38%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.625M $1.711M
YoY Change -27.84% -17.96%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.625M $1.711M
Total Long-Term Liabilities $0.00
Total Liabilities $1.388M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$2.894M -$2.802M
YoY Change -15.91% -14.53%
Common Stock $209.6K $209.6K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.512M -$1.612M
YoY Change
Total Liabilities & Shareholders Equity $113.9K $98.73K
YoY Change 122.75% 93.02%

Cashflow Statement

Concept 2023 Q4 2023 Q2 2023
OPERATING ACTIVITIES
Net Income -$56.34K -$61.33K $254.0K
YoY Change 52.5% -5.42%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$212.2K
YoY Change -33.38%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $262.2K
YoY Change -22.17%
NET CHANGE
Cash From Operating Activities -$212.2K
Cash From Investing Activities $0.00
Cash From Financing Activities $262.2K
Net Change In Cash $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$212.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001683252
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 dei Entity Public Float
EntityPublicFloat
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-160391 usd
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2095872947 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2095872947 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2095872947 shares
CY2023Q2 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
0 pure
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-55688
CY2023 dei Entity Registrant Name
EntityRegistrantName
Token Communities, Ltd.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-3709511
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
850 Tidewater Shore Loop
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 402
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Bradenton
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34208
CY2023 dei City Area Code
CityAreaCode
631
CY2023 dei Local Phone Number
LocalPhoneNumber
397-1111
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2095872947 shares
CY2023 dei Auditor Firm
AuditorFirmId
6778
CY2023 dei Auditor Name
AuditorName
Gries & Associates, LLC
CY2023 dei Auditor Location
AuditorLocation
Denver, CO
CY2023Q2 us-gaap Inventory Net
InventoryNet
46480 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
0 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
50312 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
815 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
836 usd
CY2023Q2 us-gaap Assets
Assets
98725 usd
CY2022Q2 us-gaap Assets
Assets
51148 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
190170 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
101916 usd
CY2023Q2 token Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
1520885 usd
CY2022Q2 token Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
1258676 usd
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2095872947 shares
CY2023 us-gaap Revenues
Revenues
31937 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
46823 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
63891 usd
CY2023 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
24565 usd
CY2022 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
44145 usd
CY2023 us-gaap Legal Fees
LegalFees
98668 usd
CY2022 us-gaap Legal Fees
LegalFees
129000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
115888 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
81528 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
285944 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
318564 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-254007 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-318564 usd
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
50000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
50000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-254007 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-268564 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-248815 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-268564 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-18323 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-286887 usd
CY2022 token Net Income Loss Per Shares Basic And Diluted
NetIncomeLossPerSharesBasicAndDiluted
0
CY2022 token Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2095872947 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1028756 usd
token Foreign Currency Translation Gain Amount
ForeignCurrencyTranslationGainAmount
-16491 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1205638 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1309444 usd
token Foreign Currency Translation Gain Amount
ForeignCurrencyTranslationGainAmount
-3374 usd
us-gaap Net Income Loss
NetIncomeLoss
-163626 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1476444 usd
CY2023Q1 token Foreign Currency Translation Gain Amount
ForeignCurrencyTranslationGainAmount
61253 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-29050 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1444241 usd
CY2023Q2 token Foreign Currency Translation Gain Amount
ForeignCurrencyTranslationGainAmount
-106757 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-61332 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1612330 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
254007 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
268564 usd
CY2023 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
0 usd
CY2022 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-50000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
46459 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
88254 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-212212 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-318564 usd
CY2023 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
CY2022 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
262208 usd
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
336887 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
262208 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
336887 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-48878 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-18323 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
312 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
312 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1430 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
312 usd
CY2018Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
19266000 shares
CY2018Q1 token Equity Method Investments Ownership Percentage
EquityMethodInvestmentsOwnershipPercentage
1 pure
CY2018Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
172800000 shares
CY2023 token Number Of Shares Outstanding Prior To Merger
NumberOfSharesOutstandingPriorToMerger
116466000 shares
CY2023Q2 token Surrender Stockholder Shares
SurrenderStockholderShares
19266000 shares
CY2023 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
57107 usd
CY2020Q3 token Number Of Tokens Acquired
NumberOfTokensAcquired
0 shares
CY2020Q3 token Stock Cancelled During Period Shares Acquisitions
StockCancelledDuringPeriodSharesAcquisitions
174540600 shares
CY2023Q1 us-gaap Notes Issued1
NotesIssued1
225000 usd
CY2023 us-gaap Stockholders Equity Other
StockholdersEquityOther
1612330 usd
CY2023 token Foreign Currency Translationtabletextblock
ForeignCurrencyTranslationtabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Period end: GBP to USD exchange rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.270841</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.210000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Average period: GBP to USD exchange rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">N/A</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.300000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q2 us-gaap Derivative Forward Exchange Rate1
DerivativeForwardExchangeRate1
1.270841 pure
CY2022Q2 us-gaap Derivative Forward Exchange Rate1
DerivativeForwardExchangeRate1
1.210000 pure
CY2022Q2 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
1.300000 pure
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.50 pure
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
54481 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
31000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
31000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
159170 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
70916 usd
CY2023Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
190170 usd
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
101916 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote
CY2023Q2 token Amount Due To Related Parties Current And Noncurrent
AmountDueToRelatedPartiesCurrentAndNoncurrent
1520885 usd
CY2022Q2 token Amount Due To Related Parties Current And Noncurrent
AmountDueToRelatedPartiesCurrentAndNoncurrent
1258676 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001477932-23-007616-index-headers.html Edgar Link pending
0001477932-23-007616-index.html Edgar Link pending
0001477932-23-007616.txt Edgar Link pending
0001477932-23-007616-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tkcm_10k.htm Edgar Link pending
tkcm_10kimg5.jpg Edgar Link pending
tkcm_ex311.htm Edgar Link pending
tkcm_ex312.htm Edgar Link pending
tkcm_ex321.htm Edgar Link pending
token-20230630.xsd Edgar Link pending
token-20230630_cal.xml Edgar Link unprocessable
token-20230630_def.xml Edgar Link unprocessable
token-20230630_lab.xml Edgar Link unprocessable
token-20230630_pre.xml Edgar Link unprocessable
tkcm_10k_htm.xml Edgar Link completed